These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21235343)

  • 1. SAF-A has a role in transcriptional regulation of Oct4 in ES cells through promoter binding.
    Vizlin-Hodzic D; Johansson H; Ryme J; Simonsson T; Simonsson S
    Cell Reprogram; 2011 Feb; 13(1):13-27. PubMed ID: 21235343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells.
    Verneri P; Vazquez Echegaray C; Oses C; Stortz M; Guberman A; Levi V
    Sci Rep; 2020 Mar; 10(1):5195. PubMed ID: 32251342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pluripotency transcription factor OCT4 represses heme oxygenase-1 gene expression.
    Petrone MV; Toro A; Vazquez Echegaray C; Francia MG; Solari C; Cosentino MS; Vazquez E; Guberman A
    FEBS Lett; 2021 Jul; 595(14):1949-1961. PubMed ID: 34056710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination.
    Johansson H; Simonsson S
    Aging (Albany NY); 2010 Nov; 2(11):815-22. PubMed ID: 21076177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAF-A forms a complex with BRG1 and both components are required for RNA polymerase II mediated transcription.
    Vizlin-Hodzic D; Runnberg R; Ryme J; Simonsson S; Simonsson T
    PLoS One; 2011; 6(12):e28049. PubMed ID: 22162999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 2 homodimerization rapidly reduces transcription of the pluripotency gene Nanog without dissociation of activating transcription factors.
    Santostefano KE; Hamazaki T; Pardo CE; Kladde MP; Terada N
    J Biol Chem; 2012 Aug; 287(36):30507-17. PubMed ID: 22787153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells.
    Yu HB; Kunarso G; Hong FH; Stanton LW
    J Biol Chem; 2009 Nov; 284(45):31327-35. PubMed ID: 19740739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase 1 expression is modulated by the core pluripotency transcription factors Oct4, Sox2 and Nanog in embryonic stem cells.
    Solari C; Petrone MV; Vazquez Echegaray C; Cosentino MS; Waisman A; Francia M; Barañao L; Miriuka S; Guberman A
    Mech Dev; 2018 Dec; 154():116-121. PubMed ID: 29933066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.
    Park Y; Lee JM; Hwang MY; Son GH; Geum D
    Mol Cells; 2013 Jan; 35(1):61-9. PubMed ID: 23212346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
    Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells.
    Zhang X; Zhang J; Wang T; Esteban MA; Pei D
    J Biol Chem; 2008 Dec; 283(51):35825-33. PubMed ID: 18957414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.
    Yang J; Chai L; Fowles TC; Alipio Z; Xu D; Fink LM; Ward DC; Ma Y
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19756-61. PubMed ID: 19060217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
    Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
    Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT4 supports extended LIF-independent self-renewal and maintenance of transcriptional and epigenetic networks in embryonic stem cells.
    He R; Xhabija B; Al-Qanber B; Kidder BL
    Sci Rep; 2017 Nov; 7(1):16360. PubMed ID: 29180818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of nanog by OCT4 and SOX2.
    Rodda DJ; Chew JL; Lim LH; Loh YH; Wang B; Ng HH; Robson P
    J Biol Chem; 2005 Jul; 280(26):24731-7. PubMed ID: 15860457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Oct4 in maintaining and regaining stem cell pluripotency.
    Shi G; Jin Y
    Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the protein stability and transcriptional activity of OCT4 in stem cells.
    Sohn EJ; Moon HJ; Lim JK; Kim DS; Kim JH
    Adv Biol Regul; 2021 Jan; 79():100777. PubMed ID: 33451972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.